×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
The Globe and Mail
Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth...
11 hours ago
Scholar Rock gets FDA nod to trial SMA drug with GLP-1ra in obesity
Clinical Trials Arena
Scholar Rock will be initiating a Phase II trial of its spinal muscular atrophy pipeline drug apitegromab alongside a GLP-1 receptor agonist (...
2 months ago
Insider Edward Myles Sells 6,634 Shares of Scholar Rock Holding Corp (SRRK)
Yahoo Finance
Edward Myles, COO & CFO of Scholar Rock Holding Corp (NASDAQ:SRRK), sold 6634 shares of the company on January 16, 2024, according to a...
3 months ago
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss ...
Business Wire
Based on preclinical data, SRK-439 has the potential to support healthier weight management by preserving lean mass. The efficacy and safety of...
2 months ago
Why Scholar Rock Holding Stock Soared Today
The Motley Fool
Shares of Scholar Rock Holding Corp. (SRRK -0.07%) skyrocketed as much as 35% early Thursday, then settled to trade up 13.7% as of 3 p.m. ET...
6 months ago
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
Cure SMA
Today, Scholar Rock announced that enrollment in their Phase 3 SAPPHIRE trial is now complete. The Phase 3 trial will evaluate the safety...
7 months ago
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst - Sch
Benzinga
Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key programs...
4 weeks ago
Scholar Rock Holding Corp (SRRK) Reports Q3 2023 Financial Results
Yahoo Finance
Financial Results. For the quarter ended September 30, 2023, the company reported no revenue. Research and development expense was $30.3 million...
5 months ago
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief ...
Business Wire
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy...
2 months ago
Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move ...
Yahoo Finance
The average of price targets set by Wall Street analysts indicates a potential upside of 99.1% in Scholar Rock Holding Corporation (SRRK).
5 months ago